• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于域适应和网络剪枝的轻量级深度模型用于乳腺癌HER2评分:免疫组化与苏木精-伊红组织病理学图像对比

Lightweight deep models based on domain adaptation and network pruning for breast cancer HER2 scoring: IHC vs. H&E histopathological images.

作者信息

Abdel-Hamid Lamiaa, Yogarajah Pratheepan, Tealab Safy Hosny Ahmed

机构信息

Electronics and Communication Department, Faculty of Engineering, Misr International University, Cairo, Egypt.

School of Computing, Engineering and Intelligent Systems, University of Ulster, Londonderry, United Kingdom.

出版信息

PLoS One. 2025 Sep 15;20(9):e0332362. doi: 10.1371/journal.pone.0332362. eCollection 2025.

DOI:10.1371/journal.pone.0332362
PMID:40953092
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12435681/
Abstract

Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is an aggressive cancer type that requires special diagnosis and treatment methods. Immunohistochemistry (IHC) staining effectively highlights relevant morphological structures within histopathological images yet can be expensive in terms of both labor and required laboratory equipment. Hematoxylin and eosin (H&E) images are more readily available and less expensive than IHC images as they are routinely performed for all patient samples. Lightweight models are well-suited for deployment on resource-constrained devices such as mobile phones and embedded systems, making them ideal for real-time diagnosis in rural regions and developing countries. In this study, IHC images are compared to H&E images for automatic HER2 scoring using lightweight deep models that incorporate several advanced techniques including network pruning, domain adaptation, and attention mechanisms. Two lightweight models are presented: PrunEff4 and ATHER2. PrunEff4 is a subset of EfficientNetV2B0 pruned to reduce the network parameters by ~80%. ATHER2 is a customized lightweight network that employs different sized convolutional filters along with a convolutional block attention module (CBAM). For PrunEff4 and ATHER2, transfer learning (pretraining on ImageNet) and domain-specific pretraining were employed, respectively. Different datasets were utilized in the development and final testing phases in order to effectively evaluate their generalization capability. In all experiments, both networks resulted in accuracies ranging from 97% to 100% for binary classifications and from 95.5% to 98.5% for multiclass classifications regardless of whether IHC or H&E images were utilized. Network pruning significantly reduced the network parameters whilst maintaining reliable performance. Domain-specific pretraining significantly enhanced performance, particularly in complex classification tasks such as HER2 scoring using H&E images and multiclass classifications. Both IHC and H&E stained images were suitable for deep learning-based HER2 scoring, given that the deep networks are efficiently trained for the specified task.

摘要

人表皮生长因子受体2(HER2)阳性乳腺癌是一种侵袭性癌症类型,需要特殊的诊断和治疗方法。免疫组织化学(IHC)染色能有效突出组织病理学图像中的相关形态结构,但在人力和所需实验室设备方面成本较高。苏木精和伊红(H&E)图像比IHC图像更容易获得且成本更低,因为它们是对所有患者样本常规进行的。轻量级模型非常适合部署在资源受限的设备上,如手机和嵌入式系统,这使其成为农村地区和发展中国家进行实时诊断的理想选择。在本研究中,使用结合了网络剪枝、域适应和注意力机制等多种先进技术的轻量级深度模型,将IHC图像与H&E图像进行比较,以实现HER2的自动评分。提出了两个轻量级模型:PrunEff4和ATHER2。PrunEff4是EfficientNetV2B0的一个子集,经过剪枝以将网络参数减少约80%。ATHER2是一个定制的轻量级网络,采用不同大小的卷积滤波器以及卷积块注意力模块(CBAM)。对于PrunEff4和ATHER2,分别采用了迁移学习(在ImageNet上进行预训练)和特定领域预训练。在开发和最终测试阶段使用了不同的数据集,以有效评估它们的泛化能力。在所有实验中,无论使用IHC图像还是H&E图像,两个网络在二分类中的准确率范围为97%至100%,在多分类中的准确率范围为95.5%至98.5%。网络剪枝在保持可靠性能的同时显著减少了网络参数。特定领域预训练显著提高了性能,特别是在复杂的分类任务中,如使用H&E图像进行HER2评分和多分类。鉴于深度网络针对指定任务进行了有效训练,IHC和H&E染色图像都适用于基于深度学习的HER2评分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/e24e337047cf/pone.0332362.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/b0aecaba912b/pone.0332362.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/30c791079a70/pone.0332362.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/1080353133b6/pone.0332362.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/3f037d183c8b/pone.0332362.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/bf611016365d/pone.0332362.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/fc98db77fa44/pone.0332362.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/5ea0ffeb5d4e/pone.0332362.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/48533404ab5b/pone.0332362.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/b98c7b0a1430/pone.0332362.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/583af6ba34ee/pone.0332362.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/f0db1b0685e2/pone.0332362.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/e24e337047cf/pone.0332362.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/b0aecaba912b/pone.0332362.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/30c791079a70/pone.0332362.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/1080353133b6/pone.0332362.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/3f037d183c8b/pone.0332362.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/bf611016365d/pone.0332362.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/fc98db77fa44/pone.0332362.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/5ea0ffeb5d4e/pone.0332362.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/48533404ab5b/pone.0332362.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/b98c7b0a1430/pone.0332362.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/583af6ba34ee/pone.0332362.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/f0db1b0685e2/pone.0332362.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f43/12435681/e24e337047cf/pone.0332362.g012.jpg

相似文献

1
Lightweight deep models based on domain adaptation and network pruning for breast cancer HER2 scoring: IHC vs. H&E histopathological images.基于域适应和网络剪枝的轻量级深度模型用于乳腺癌HER2评分:免疫组化与苏木精-伊红组织病理学图像对比
PLoS One. 2025 Sep 15;20(9):e0332362. doi: 10.1371/journal.pone.0332362. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Leveraging a foundation model zoo for cell similarity search in oncological microscopy across devices.利用基础模型库进行跨设备肿瘤显微镜检查中的细胞相似性搜索。
Front Oncol. 2025 Jun 18;15:1480384. doi: 10.3389/fonc.2025.1480384. eCollection 2025.
4
Short-Term Memory Impairment短期记忆障碍
5
Deep Learning for the Early Detection of Invasive Ductal Carcinoma in Histopathological Images: Convolutional Neural Network Approach With Transfer Learning.基于深度学习的组织病理学图像中浸润性导管癌早期检测:采用迁移学习的卷积神经网络方法
JMIR Form Res. 2025 Aug 21;9:e62996. doi: 10.2196/62996.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
Development and Validation of a Convolutional Neural Network Model to Predict a Pathologic Fracture in the Proximal Femur Using Abdomen and Pelvis CT Images of Patients With Advanced Cancer.利用晚期癌症患者腹部和骨盆 CT 图像建立卷积神经网络模型预测股骨近端病理性骨折的研究
Clin Orthop Relat Res. 2023 Nov 1;481(11):2247-2256. doi: 10.1097/CORR.0000000000002771. Epub 2023 Aug 23.
8
HER2 Status Assessment in Endometrial Serous Carcinoma: Comparative Analysis of Two Proposed Testing and Interpretation Algorithms.子宫内膜浆液性癌中HER2状态评估:两种提议的检测与解读算法的比较分析
Int J Gynecol Pathol. 2024 Jan 1;43(1):4-14. doi: 10.1097/PGP.0000000000000943. Epub 2023 Jun 9.
9
Prediction of breast cancer HER2 status changes based on ultrasound radiomics attention network.
Comput Methods Programs Biomed. 2025 Nov;271:108987. doi: 10.1016/j.cmpb.2025.108987. Epub 2025 Aug 5.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

本文引用的文献

1
Deep learning-based classification of breast cancer molecular subtypes from H&E whole-slide images.基于深度学习从苏木精和伊红全切片图像对乳腺癌分子亚型进行分类
J Pathol Inform. 2024 Nov 17;16:100410. doi: 10.1016/j.jpi.2024.100410. eCollection 2025 Jan.
2
Insights into AI advances in immunohistochemistry for effective breast cancer treatment: a literature review of ER, PR, and HER2 scoring.人工智能在免疫组织化学中助力有效乳腺癌治疗的进展洞察:雌激素受体、孕激素受体和人表皮生长因子受体2评分的文献综述
Curr Med Res Opin. 2025 Jan;41(1):115-134. doi: 10.1080/03007995.2024.2445142. Epub 2025 Jan 6.
3
A Survey on Deep Neural Network Pruning: Taxonomy, Comparison, Analysis, and Recommendations.
深度神经网络剪枝研究综述:分类、比较、分析与建议
IEEE Trans Pattern Anal Mach Intell. 2024 Dec;46(12):10558-10578. doi: 10.1109/TPAMI.2024.3447085. Epub 2024 Nov 6.
4
Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides.弱监督深度学习模型可实现从 H&E 染色切片预测 HER2 低表达。
Breast Cancer Res. 2024 Aug 19;26(1):124. doi: 10.1186/s13058-024-01863-0.
5
HER2GAN: Overcome the Scarcity of HER2 Breast Cancer Dataset Based on Transfer Learning and GAN Model.HER2GAN:基于迁移学习和 GAN 模型克服 HER2 乳腺癌数据集的稀缺性。
Clin Breast Cancer. 2024 Jan;24(1):53-64. doi: 10.1016/j.clbc.2023.09.014. Epub 2023 Sep 29.
6
The enlightening role of explainable artificial intelligence in medical & healthcare domains: A systematic literature review.可解释人工智能在医疗保健领域中的启示作用:系统文献综述。
Comput Biol Med. 2023 Nov;166:107555. doi: 10.1016/j.compbiomed.2023.107555. Epub 2023 Oct 4.
7
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer.符合 2023 年 ASCO/CAP 更新和 2023 年 ESMO 关于 HER2 低乳腺癌共识声明的 HER2 检测标准化病理报告。
Virchows Arch. 2024 Jan;484(1):3-14. doi: 10.1007/s00428-023-03656-w. Epub 2023 Sep 28.
8
HAHNet: a convolutional neural network for HER2 status classification of breast cancer.HAHNet:一种用于乳腺癌 HER2 状态分类的卷积神经网络。
BMC Bioinformatics. 2023 Sep 20;24(1):353. doi: 10.1186/s12859-023-05474-y.
9
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update.人表皮生长因子受体 2 检测在乳腺癌中的应用:ASCO-美国病理学家学会指南更新。
J Clin Oncol. 2023 Aug 1;41(22):3867-3872. doi: 10.1200/JCO.22.02864. Epub 2023 Jun 7.
10
Strategies for Enhancing the Multi-Stage Classification Performances of HER2 Breast Cancer from Hematoxylin and Eosin Images.从苏木精和伊红图像增强HER2乳腺癌多阶段分类性能的策略
Diagnostics (Basel). 2022 Nov 16;12(11):2825. doi: 10.3390/diagnostics12112825.